pertuzumab Injection

Brand(s)
Perjeta
Category(s)
prescription
SPL Type(s)
Human Prescription
Master SPL
Genentech, Inc. (2015-06-05)
Oldest Current Product
2012-06-08
License(s)
BLA
RxNORM
INJECTION\PERTUZUMAB
SPL Active
INTRAVENOUS\INJECTION, SOLUTION, CONCENTRATE\PERTUZUMAB
SPL Moiety
INTRAVENOUS\INJECTION, SOLUTION, CONCENTRATE\PERTUZUMAB

product(s) by strength(s)

14 ml pertuzumab 30 mg/ml injection

original product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1502420145PerjetaBLAGenentech, Inc.2012-06-08PERTUZUMABINTRAVENOUSINJECTION, SOLUTION, CONCENTRATE12540917f85d17-ab71-4f5b-9fe3-0b8c822f69ff

application(s)

#idtitleapprovedtradenamesfda division
1125409pertuzumab Application2012-06-08PerjetaCDER

spl(s)

#idtitlecategorytypelabelerlabeler actlast updateversionproduct(s)
117f85d17-ab71-4f5b-9fe3-0b8c822f69ff (view SPL)These highlights do not include all the information needed to use PERJETA safely and effectively. See full prescribing information for PERJETA. PERJETA (pertuzumab) Injection, for intravenous use Initial U.S. Approval: 2012prescriptionHuman PrescriptionGenentech, Inc.ANALYSIS, API MANUFACTURE, LABEL, MANUFACTURE, PACK2015-06-055502420145

Data from: FDAOB, FDAPB, LOINC, MTHSPL, NDFRT, NCIT, RxNORM, UNII